WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark NORTHERA was filed as Word mark on 05/18/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1599772 |
| Register number | VR202100435 |
| Countries | 
|
| Base trademark |
No. VR 2021 00435,
February 26, 2021
|
| Application date | May 18, 2021 |
| Expiration date | May 18, 2031 |
Trademark owner
Ottiliavej 9
2500 Valby
DK
2500 Valby
DK
goods and services
05
Pharmaceuticals and medical preparations and substances;
vaccines; pharmaceutical preparations and substances for the
prevention and treatment of disorders and diseases in,
generated by or acting on the central nervous system;
pharmaceutical preparations and substances acting on the
central nervous system; central nervous system stimulants;
pharmaceutical preparations and substances for the
prevention and treatment of psychiatric and neurological
disorders and diseases; pharmaceutical preparations and
substances used for the prevention, management and treatment
of headaches, migraines, pain, immune and inflammatory
disorders and diseases, dementia, Alzheimer's disorder and
disease, seizures, stroke, depression, cognitive impairment,
cognitive disorders and diseases, mood disorders, psychosis,
anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS),
sclerosis, porphyria, Huntington's disorder and disease,
insomnia, Parkinson's disorder and disease, falls, movement
disorders and diseases, dyskinesia, poor or absent motor
functions, tremor, schizophrenia, bipolar disorder and
disease, mania, attention deficit hyperactivity disorder
(ADHD), post-traumatic stress disorder (PTSD), agitation,
aggression, autism, melancholy, obsessive-compulsive
disorder (OCD), Tourette's syndrome, progressive
supranuclear palsy (PSP), restlessness, akathisia, fatigue,
somnolence, nausea, cancer, alcoholism and dependency;
pharmaceutical preparations for the prevention and treatment
of neurogenic orthostatic hypotension (NOH), low blood
pressure, dizziness, lightheadedness gait stiffness;
preparations, substances, reagents and agents for diagnostic
and medical purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 28, 2022 | 2022/52 Gaz | MY | Rejection |
| November 21, 2022 | 2022/47 Gaz | IS | Rejection |
| July 31, 2022 | 2022/31 Gaz | ID | Rejection |
| July 5, 2022 | 2022/27 Gaz | Deletion | |
| June 28, 2022 | 2022/27 Gaz | VN | Rejection |
| June 3, 2022 | 2022/23 Gaz | CH | Rejection |
| May 16, 2022 | 2022/20 Gaz | NO | Rejection |
| February 25, 2022 | 2022/8 Gaz | GB | Rejection |
| January 17, 2022 | 2022/7 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| December 31, 2021 | 2022/1 Gaz | SG | Rejection |
| December 21, 2021 | 2021/51 Gaz | IN | Rejection |
| July 19, 2021 | 2021/31 Gaz | PH | Rejection |
| May 18, 2021 | 2021/24 Gaz | DK | Registration |
ID: 141599772